| 1 | Study | 1.37% | |
| 2 | New | 1.37% | |
| 3 | Lymphoma | 1.37% | |
| 4 | Covid | 1.37% | |
| 5 | Pivotal | 0.68% | |
| 6 | Control | 0.68% | |
| 7 | Reid | 0.68% | |
| 8 | Reduced | 0.68% | |
| 9 | Offers | 0.68% | |
| 10 | Factors | 0.68% | |
| 11 | Titers | 0.68% | |
| 12 | Gut | 0.68% | |
| 13 | Central | 0.68% | |
| 14 | Speckle-Tracking | 0.68% | |
| 15 | Burlington | 0.68% | |
| 16 | Pump | 0.68% | |
| 17 | Academic | 0.68% | |
| 18 | America | 0.68% | |
| 19 | Detection | 0.68% | |
| 20 | Antibody | 0.68% | |
| 21 | Indicator | 0.68% | |
| 22 | Inhibitor | 0.68% | |
| 23 | Rapid | 0.68% | |
| 24 | Highlights | 0.68% | |
| 25 | Parsons | 0.68% | |
| 26 | Overlap | 0.68% | |
| 27 | Complexity | 0.68% | |
| 28 | NWEA | 0.68% | |
| 29 | Comorbidities | 0.68% | |
| 30 | Therapy | 0.68% | |
| 31 | Family | 0.68% | |
| 32 | Elderly | 0.68% | |
| 33 | Antimuscarinic | 0.68% | |
| 34 | Multiple | 0.68% | |
| 35 | FFMI | 0.68% | |
| 36 | Multimodal | 0.68% | |
| 37 | Fracture | 0.68% | |
| 38 | Patients | 0.68% | |
| 39 | Ultra-Sensitive | 0.68% | |
| 40 | Targeting | 0.68% | |
| 41 | Diabetes | 0.68% | |
| 42 | mRNA | 0.68% | |
| 43 | Assay | 0.68% | |
| 44 | Europe | 0.68% | |
| 45 | Metabolites | 0.68% | |
| 46 | Recognizing | 0.68% | |
| 47 | Acetylcholine | 0.68% | |
| 48 | Receptor | 0.68% | |
| 49 | Association | 0.68% | |
| 50 | Blindness | 0.68% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||